Digestives & Intestinal Remedies - Oman

  • Oman
  • In Oman, the Digestives & Intestinal Remedies market market generated a revenue of US$27.19m in 2024.
  • It is projected to experience an annual growth rate of 1.74% (CAGR 2024-2029).
  • When compared globally, in China leads the market with a revenue of US$4,408.00m in 2024.
  • In terms of per capita income, individuals in Oman generated US$5.77 in revenue in 2024.
  • Oman's Digestives & Intestinal Remedies market is witnessing a surge in demand for herbal and natural remedies.

Key regions: Canada, United States, Australia, Brazil, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Oman is witnessing steady growth due to increasing customer preferences for natural and herbal remedies, as well as the rising incidence of digestive disorders.

Customer preferences:
Customers in Oman are increasingly turning towards natural and herbal remedies for digestive issues. This shift in preference can be attributed to the growing awareness about the potential side effects of synthetic medications. Natural remedies are perceived as safer and more gentle on the digestive system. Additionally, customers are also seeking products that provide long-term relief rather than just temporary solutions. As a result, there is a growing demand for products that promote digestive health and support the overall well-being of individuals.

Trends in the market:
One of the key trends in the Digestives & Intestinal Remedies market in Oman is the increasing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for the digestive system. They help restore the natural balance of bacteria in the gut, thereby improving digestion and reducing gastrointestinal issues. The demand for probiotic supplements and foods has been on the rise as consumers are becoming more aware of the importance of maintaining a healthy gut microbiome.Another trend in the market is the growing availability of over-the-counter digestive remedies. This allows customers to easily access and purchase products without the need for a prescription. The convenience and accessibility of these products have contributed to their increasing popularity among consumers.

Local special circumstances:
Oman has a relatively high prevalence of digestive disorders, including conditions like irritable bowel syndrome (IBS) and acid reflux. These conditions can cause discomfort and affect the quality of life for individuals. As a result, there is a significant demand for digestive remedies in the market. Local healthcare providers and pharmacies play a crucial role in meeting this demand by offering a wide range of products to address various digestive issues.

Underlying macroeconomic factors:
The economic stability and increasing disposable income in Oman have contributed to the growth of the Digestives & Intestinal Remedies market. As people have more purchasing power, they are willing to invest in products that improve their digestive health and overall well-being. Additionally, the government's focus on healthcare and wellness initiatives has also created a favorable environment for the market to thrive.In conclusion, the Digestives & Intestinal Remedies market in Oman is experiencing growth driven by customer preferences for natural remedies, the increasing popularity of probiotics, the availability of over-the-counter products, the high prevalence of digestive disorders, and the favorable macroeconomic factors. As the market continues to evolve, it is expected to witness further expansion and innovation in product offerings to cater to the diverse needs of consumers.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)